Trials / Enrolling By Invitation
Enrolling By InvitationNCT07373691
A Study on Multimodal Prognostic Scoring of Advanced PDAC.
A Multimodal Prognostic Model for Advanced Pancreatic Ductal Adenocarcinoma Patients: a Retrospective and Prospective, Observational, Multicenter Study.
- Status
- Enrolling By Invitation
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- RenJi Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to construct unimodal and multimodal prediction models for overall survival (OS), progression free survival (PFS), and treatment response (complete response+partial response) of advanced first-line chemotherapy based on the imaging, pathological, and genomic characteristics of patients, and evaluate their predictive efficacy.
Conditions
Timeline
- Start date
- 2025-03-02
- Primary completion
- 2026-03-01
- Completion
- 2027-03-01
- First posted
- 2026-01-28
- Last updated
- 2026-01-28
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07373691. Inclusion in this directory is not an endorsement.